Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022 Motoko YanagitaSatoru MutoNaoki Kashihara Guideline Open access 25 October 2023 Pages: 85 - 122
Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022 Motoko YanagitaSatoru MutoNaoki Kashihara Correction Open access 09 December 2023 Pages: 123 - 124
The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances Xinping ChenXuan LiZhentao Guo Review article 17 October 2023 Pages: 125 - 135
Alleviation effects of epigallocatechin-3-gallate against acute kidney injury following severe burns Hongyan XuYichao PangYi Luo Original article Open access 17 October 2023 Pages: 136 - 143
eGFR slope as a surrogate endpoint for end-stage kidney disease in patients with diabetes and eGFR > 30 mL/min/1.73 m2 in the J-DREAMS cohort Yuka SugawaraEiichiro KandaMasaomi Nangaku Original article Open access 09 October 2023 Pages: 144 - 152
Tenapanor for peritoneal dialysis patients with hyperphosphatemia: a phase 3 trial Masaaki NakayamaShuhei KobayashiMasafumi Fukagawa Original article Open access 01 November 2023 Pages: 153 - 164
Survival benefit of living donor kidney transplantation in patients on hemodialysis Shunsuke GotoHideki FujiiShinichi Nishi Original article Open access 21 October 2023 Pages: 165 - 174
Potential influence of dietary guidance for advanced chronic kidney disease: comment on “Prevalence of hyponatremia and associated factors in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry (FKR) study” Hirofumi SumiNaoto Tominaga Letter to the editor 17 October 2023 Pages: 175 - 176
Development of pauci-immune necrotizing glomerulonephritis during pembrolizumab treatment Jun MatsumotoYosuke SakaTomohiko Naruse Letter to the editor 17 October 2023 Pages: 177 - 178
Correction to: Efficacy and safety of entecavir for hepatitis B virus-associated glomerulonephritis with renal insufficiency Yani YuLingyu XuWei Jiang Correction 04 January 2024 Pages: 179 - 179